Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. (Q54190983)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Kenji Fukuno

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Takeshi Hara

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Hisashi Tsurumi

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Yuhei Shibata

4

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Ryoko Mabuchi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Nobuhiko Nakamura

6

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Junichi Kitagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Masahito Shimizu

8

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Hiroyasu Ito

9

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Kuniaki Saito

10

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Hisataka Moriwaki

11

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

publication date

3 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

56

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

1398-1405

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

(-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Inhibition of carcinogenesis by tea.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Screening of anticarcinogenic ingredients in tea polyphenols

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Inflammation and cancer: how hot is the link?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.953150

21 January 2018

Identifiers

10.3109/10428194.2014.953150

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/25248875

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54190983&oldid=1521261823"